Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis - Chapman & Hall/CRC Biostatistics Series (Hardback)
  • Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis - Chapman & Hall/CRC Biostatistics Series (Hardback)
zoom

Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis - Chapman & Hall/CRC Biostatistics Series (Hardback)

(editor), (editor), (editor)
£70.99
Hardback 454 Pages / Published: 18/07/2016
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket

Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis provides statisticians with an understanding of the critical challenges currently encountered in oncology trials. Well-known statisticians from academic institutions, regulatory and government agencies (such as the U.S. FDA and National Cancer Institute), and the pharmaceutical industry share their extensive experiences in cancer clinical trials and present examples taken from actual trials.

The book covers topics that are often perplexing and sometimes controversial in cancer clinical trials. Most of the issues addressed are also important for clinical trials in other settings. After discussing general topics, the book focuses on aspects of early and late phase clinical trials. It also explores personalized medicine, including biomarker-based clinical trials, adaptive clinical trial designs, and dynamic treatment regimes.

Publisher: Taylor & Francis Inc
ISBN: 9781498706889
Number of pages: 454
Weight: 771 g
Dimensions: 235 x 156 x 30 mm


MEDIA REVIEWS

"The chapters on endpoints and safety are a must read for anyone working in this field. And for statisticians involved in the design of cancer trials, the diverse options of design and sample size calculations are well covered."
~International Society for Clinical Biostatistics

"This book provides a comprehensive summary of common controversial issues frequently encountered in oncology trials. Individual issues are addressed by well-known statisticians from academic institutions, regulatory, and government agencies and pharmaceutical industry. In summary, this is an excellent book covering commonly encountered controversial issues for cancer clinical trials. It can be an excellent resource for statisticians working in oncology drug development."
~Journal of Biopharmaceutical Graphics, Steven Sun

You may also be interested in...

The Biology of Cancer
Added to basket
Oxford Handbook of Clinical Haematology
Added to basket
£36.99
Part-work (fascículo)
When I Die
Added to basket
£8.99
Paperback
Cancer: A Very Short Introduction
Added to basket
Lecture Notes: Oncology
Added to basket
Life, Cancer & God
Added to basket
£16.99
Paperback
Beat Cancer
Added to basket
£14.99
Paperback
Oxford Handbook of Oncology
Added to basket
£36.99
Part-work (fascículo)
B is for Breast Cancer
Added to basket
Radical Remission
Added to basket
Added Time
Added to basket
£6.99
Paperback
Physics for Clinical Oncology
Added to basket
Oncology Pocketcard Set
Added to basket
Malignant
Added to basket
£25.00
Paperback
The Cancer Survivor's Companion
Added to basket
Cancer
Added to basket
£12.50
Paperback

Please sign in to write a review

Your review has been submitted successfully.